Yiming Huang

Oct 23, 2023 | nature.com | Yicheng Guo |Liyuan Liu |Manoj Nair |Sho Iketani |Yiming Huang |Adam S. Lauring | +3 more

AbstractA SARS-CoV-2 Omicron subvariant, BA.2.86, has emerged and spread to numerous countries worldwide, raising alarm because its spike protein contains 34 additional mutations compared to its BA.2 predecessor1. We examined its antigenicity using human sera and monoclonal antibodies (mAbs). Reassuringly, BA.2.86 was not more resistant to human sera than the currently dominant XBB.1.5 and EG.5.1, indicating that the new subvariant would not have a growth advantage in this regard.